DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 4521--------------------------------------------------
       (Abst.) Siponimod following alemtuzumab for SPMS...
   DIR By: agate
       Date: August 18, 2024, 3:36 pm
       ---------------------------------------------------------
       From PubMed (August 18, 2024)--"Siponimod following alemtuzumab
       for secondary progressive multiple sclerosis: Investigating
       sequential therapy--a case series":
  HTML https://pubmed.ncbi.nlm.nih.gov/39151236/
       --- Quote ---
       > The prescription of subsequent therapies following
       Alemtuzumab, as mandated by label guidance for a treatment-free
       period of at least 5 years, presents a complex challenge,
       particularly if there is concurrent conversion to secondary
       progressive disease course.
       --- End Quote ---
       That 5-year wait before starting another MS treatment after
       stopping alemtuzumab would probably be a drawback for many
       patients.
       *****************************************************
       Page 1 of 1